78 related articles for article (PubMed ID: 26408746)
1. Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients.
Rades D; Dahlke M; Dziggel L; Janssen S; Bajrovic A; Trang NT; Khoa MT; Schild SE
Anticancer Res; 2015 Oct; 35(10):5701-4. PubMed ID: 26408746
[TBL] [Abstract][Full Text] [Related]
2. Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.
de Azevedo Santos TR; Tundisi CF; Ramos H; Maia MA; Pellizzon AC; Silva ML; Fogaroli RC; Chen MJ; Suzuki SH; Dias JE; Sanematsu PI; de Castro DG
Radiat Oncol; 2015 Mar; 10():63. PubMed ID: 25884621
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
[TBL] [Abstract][Full Text] [Related]
4. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
5. A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery.
Rades D; Dahlke M; Gebauer N; Bartscht T; Hornung D; Trang NT; Phuong PC; Khoa MT; Gliemroth J
Anticancer Res; 2015 Oct; 35(10):5515-8. PubMed ID: 26408718
[TBL] [Abstract][Full Text] [Related]
6. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.
Rades D; Huttenlocher S; Dahlke M; Hornung D; Blanck O; Van Thai P; Trang NT; Khoa MT; Schild SE
Anticancer Res; 2014 Dec; 34(12):7309-13. PubMed ID: 25503165
[TBL] [Abstract][Full Text] [Related]
8. Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases.
Noel G; Bollet MA; Noel S; Feuvret L; Boisserie G; Tep B; Delattre JY; Baillet F; Ambroise Valery C; Cornu P; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1555-61. PubMed ID: 16024180
[TBL] [Abstract][Full Text] [Related]
9. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
10. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
11. Fractionated stereotactic radiosurgery for large brain metastases.
Wegner RE; Leeman JE; Kabolizadeh P; Rwigema JC; Mintz AH; Burton SA; Heron DE
Am J Clin Oncol; 2015 Apr; 38(2):135-9. PubMed ID: 23563213
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
Moraes FY; Winter J; Atenafu EG; Dasgupta A; Raziee H; Coolens C; Millar BA; Laperriere N; Patel M; Bernstein M; Kongkham P; Zadeh G; Conrad T; Chung C; Berlin A; Shultz DB
Neuro Oncol; 2019 Feb; 21(2):242-251. PubMed ID: 30265328
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes using CyberKnife for brain metastases from lung cancer.
Tamari K; Suzuki O; Hashimoto N; Kagawa N; Fujiwara M; Sumida I; Seo Y; Isohashi F; Yoshioka Y; Yoshimine T; Ogawa K
J Radiat Res; 2015 Jan; 56(1):151-8. PubMed ID: 25344929
[TBL] [Abstract][Full Text] [Related]
16. Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
Chon H; Yoon K; Lee D; Kwon DH; Cho YH
J Neurooncol; 2019 Oct; 145(1):49-56. PubMed ID: 31420793
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels.
Rades D; Hornung D; Blanck O; Martens K; Khoa MT; Trang NT; Hüppe M; Terheyden P; Gliemroth J; Schild SE
Strahlenther Onkol; 2014 Sep; 190(9):786-91. PubMed ID: 24663288
[TBL] [Abstract][Full Text] [Related]
18. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.
Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
Strahlenther Onkol; 2004 Sep; 180(9):590-6. PubMed ID: 15378190
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
